# Livmarli

NDC: 79378-110
Generic name: maralixibat chloride
Labeler / Manufacturer: Mirum Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20210929

FDA application: NDA214662

## Active ingredients

- MARALIXIBAT CHLORIDE: 9.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"79378-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=79378-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64000394-1ef6-4e76-8ba8-11f25ba1b167